Kamada Ltd
NASDAQ:KMDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
M
|
MTR Corp Ltd
XMUN:MRI
|
HK |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
H
|
Hyulim ROBOT Co Ltd
KOSDAQ:090710
|
KR |
|
Zscaler Inc
F:0ZC
|
US |
|
Asia Energy Logistics Group Ltd
F:EJ1C
|
HK |
Intrinsic Value
Is KMDA undervalued or overvalued?
See the intrinsic value estimate for Kamada Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
KMDA looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with KMDA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Kamada Does
Kamada Ltd. is a biopharmaceutical company that makes plasma-derived medicines, which are treatments made from proteins found in human blood plasma. Its products are used mainly for rare and serious conditions such as immune disorders, lung disease, and certain bleeding or deficiency problems. The company also develops some products through partnerships and sells them in regulated pharmaceutical markets.
- Headquarters
- Israel IL
- Employees
- 393
- IPO date
- Aug 1, 2005
Kamada has a narrow economic moat
Kamada Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Earnings Waterfall
Kamada Ltd
The intrinsic value for Kamada Ltd (KMDA) under the Base Case is hidden USD.
Compared with the current market price of 7.735 USD, the stock appears hidden.